Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nejla Ozirmak Lermi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|September 25, 2023
Ethanol Drives Evolution of Hsp90-Dependent Robustness by Redundancy in Yeast DomesticationDipak Patel, Hatim Amiji, William Shropshire, et al.
Science (New York, N.Y.)|July 25, 2024
Selection for robust metabolism in domesticated yeasts is driven by adaptation to Hsp90 stressNatalia Condic, Hatim Amiji, Dipak Patel, et al.
Journal for Immunotherapy of Cancer|August 8, 2025
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitorsOmar Pacha, Anisha B Patel, Jonathan L Curry, et al.
Plos Genetics|April 21, 2022
Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancerNejla Ozirmak Lermi, Stanton B Gray, Charles M Bowen, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Nature Communications|June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinomaLauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|September 25, 2023
Ethanol Drives Evolution of Hsp90-Dependent Robustness by Redundancy in Yeast DomesticationDipak Patel, Hatim Amiji, William Shropshire, et al.
Science (New York, N.Y.)|July 25, 2024
Selection for robust metabolism in domesticated yeasts is driven by adaptation to Hsp90 stressNatalia Condic, Hatim Amiji, Dipak Patel, et al.
Journal for Immunotherapy of Cancer|August 8, 2025
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitorsOmar Pacha, Anisha B Patel, Jonathan L Curry, et al.
Plos Genetics|April 21, 2022
Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancerNejla Ozirmak Lermi, Stanton B Gray, Charles M Bowen, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Nature Communications|June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinomaLauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
Pageof 1